Taiwan's TTY Biopharm Opens $100 Million Drug-Production Plant In China
This article was originally published in PharmAsia News
Executive Summary
Taiwan's TTY Biopharm said it has opened a $100 million drug-production facility in China, operated by its subsidiary.